Hengbin Wang, PhD, is a Professor in the Division of Hematology, Oncology and Palliative Care at Virginia Commonwealth University School of Medicine and a member of the Cancer Biology Program at VCU Massey Comprehensive Cancer Center. His research focuses on epigenetic and chromatin-based mechanisms in cancer and development, including Polycomb regulation, histone ubiquitination, chromatin remodeling, and transcriptional control. His laboratory studies the roles of RSF1, PRC1, RNF2, USP16, and H2AK119 ubiquitination in breast and ovarian cancer, mitochondrial function, and cell-fate regulation. Dr. Wang’s work combines molecular and cellular biology, genomics, proteomics, structural biology, and translational cancer models to identify mechanisms and therapeutic vulnerabilities in cancer. Key words: Epigenetics, Chromatin biology, Histone ubiquitination, Polycomb group proteins, Transcriptional regulation, Breast cancer, Ovarian cancer, Mitochondrial function, Cancer therapeutics